A fast-growing San Francisco Bay Area biotech firm has slammed the brakes on its real estate expansion plan, canceling a 10-year lease agreement it signed only a year ago as it joins other life science companies in their efforts to conserve costs.
A fast-growing San Francisco Bay Area biotech firm has slammed the brakes on its real estate expansion plan, canceling a 10-year lease agreement it signed only a year ago as it joins other life science companies in their efforts to conserve costs.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
Two Tower Pl, South San Francisco, CA